Centessa Pharmaceuticals Plc (CNTA)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Centessa Pharmaceuticals Plc (CNTA)
Go deeper and ask any question about CNTA
Company Performance
Current Price
as of Sep 17, 2024$16.28
P/E Ratio
N/A
Market Cap
$2.09B
Description
Centessa Pharmaceuticals Plc operates as clinical-stage pharmaceutical company, which engages in discovering and developing medicines that delivers transformational to patients. Its portfolio include preclinical to phase three uncorrelated programs spanning diseases with high unmet need across oncology, hematology, immunology, inflammation, neuroscience, and rare diseases. The company was founded on October 26, 2020 and is headquartered in Altrincham, the United Kingdom.
Metrics
Overview
- HQAltrincham, CA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerCNTA
- Price$16.28-1.09%
Trading Information
- Market Cap$2.09B
- Float66.72%
- Average Daily Volume (1m)942,431
- Average Daily Volume (3m)520,139
- EPS-$1.56
Company
- Revenue$6.91M
- Rev Growth (1yr)N/A
- Net Income-$43.87M
- Gross MarginN/A
- EBITDA MarginN/A
- EBITDA-$43.79M
- EV$779.50M
- EV/Revenue112.77
- P/EN/A
- P/S257.86
Documents
SEC Filings
Factset Street Account